Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany†

PURPOSE: A prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain–Barré syndrome (GBS) and its variant Fisher syndrome (FS). METHODS: Pote...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmacoepidemiol Drug Saf
Main Authors: Prestel, Jürgen, Volkers, Peter, Mentzer, Dirk, Lehmann, Helmar C, Hartung, Hans-Peter, Keller-Stanislawski, Brigitte
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2014
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282476/
https://ncbi.nlm.nih.gov/pubmed/24817531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3638
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares